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Corridor disease (CD) is a fatal condition of cattle caused by buffalo-derived Theileria
parva. Unlike the related condition, East Coast fever, which results from infection with
cattle-derived T. parva, CD has not been extensively studied. We describe in detail the
clinical and laboratory findings in cattle naturally infected with buffalo-derived T. parva.
Forty-six cattle were exposed to buffalo-derived T. parva under field conditions at the Ol
Pejeta Conservancy, Kenya, between 2013 and 2018. The first signs of disease observed
in all animals were nasal discharge (mean day of onset was 9 days post-exposure),
enlarged lymph nodes (10 days post-exposure), and pyrexia (13.7 days post-exposure).
Coughing and labored breathing were observed in more than 50% of animals (14 days
post-exposure). Less commonly observed signs, corneal edema (22%) and diarrhea
(11%), were observed later in the disease progression (19 days post-exposure). All
infections were considered clinically severe, and 42 animals succumbed to infection.
The mean time to death across all studies was 18.4 days. The mean time from onset
of clinical signs to death was 9 days and from pyrexia to death was 4.8 days, indicating
a relatively short duration of clinical illness. There were significant relationships between
days to death and the days to first temperature (chi2 = 4.00, p = 0.046), and days
to peak temperature (chi2 = 25.81, p = 0.001), animals with earlier onset pyrexia died
sooner. These clinical indicators may be useful for assessing the severity of disease in the
future. All infections were confirmed by the presence of macroschizonts in lymph node
biopsies (mean time to parasitosis was 11 days). Piroplasms were detected in the blood
of two animals (4%) and 20 (43%) animals seroconverted. In this study, we demonstrate
the successful approach to an experimental field study for CD in cattle. We also describe
the clinical progression of CD in naturally infected cattle, including the onset and severity
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of clinical signs and pathology. Laboratory diagnoses based on examination of blood
samples are unreliable, and alternatives may not be available to cattle keepers. The rapid
development of CD requires recognition of the clinical signs, which may be useful for
early diagnosis of the disease and effective intervention for affected animals.
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INTRODUCTION
Theileria parva, an apicomplexan protozoal parasite, is the
causative agent of both East Coast fever (ECF) and corridor
disease (CD) in cattle. ECF is caused by cattle-derived T. parva,
and CD is caused by buffalo-derived T. parva. Historically, it was
considered that the two diseases were caused by two separate
Theileria parasites, T. parva parva and T. parva lawrencei (1).
More recently, however, it was discerned through genetic analysis
that the two diseases are caused by the same parasite, T. parva,
with differences in pathogenicity and virulence (2).
A great deal of research effort has been focused on
understanding and controlling T. parva infections since the
first recorded significant loss of cattle in the 1890s (2). A large
amount of research on T. parva infection has been conducted
in controlled challenge experiments (3, 4). The majority of
research has focused on ECF, including, but not limited to,
identifying parasite antigens recognized by the bovine immune
system, assessment of the genetic diversity of the parasite,
and the development and testing of new subunit vaccines
(5–8). In contrast, detailed research of CD is limited, and
detailed descriptions regarding the clinical manifestations of CD
and experimental infections have been incomplete. The first
description of the clinical presentation of CD was published
in 1955 but was limited to a list of the clinical signs (9). A
comparison of the disease progression between ECF and CD was
conducted in 1980 with a needle challenge experiment using T.
parva stabilates from cattle and buffalo, respectively (10). A more
recent publication described CD outbreaks in South Africa at the
wildlife/livestock interface but did not give a detailed description
of the clinical disease in the affected animals (11).
The clinical presentation of both ECF and CD includes
enlarged lymph nodes, pyrexia, lacrimation, nasal discharge,
anorexia, teeth grinding, loss of body condition, diarrhea, labored
breathing and coughing, recumbency, and death (9, 12, 13). CD
has previously been distinguished from ECF by lower parasite
levels and rare detection of piroplasms (1, 9).
Diagnosis of ECF and CD in the field is predominantly
clinical, although there are confirmatory tests available. The
main diagnostic test available to researchers and cattle keepers
is the detection of macroschizonts in Giemsa stained lymph node
aspirates, although serological and molecular assays are available
(14). There are currently no diagnostic methods to distinguish
between infection with ECF and CD.
Control methods include reducing exposure to the parasite
by controlling the tick vector through the use of acaricides
and the use of a vaccination method known as the infection
and treatment method (ITM) (15, 16). Immunization is
achieved by administering a ground homogenate of infected
sporozoite-containing ticks while simultaneously preventing the
progression of the disease by administering a dose of long-
acting oxytetracycline (16). The efficacy of the ITM in preventing
CD is variable; ITM is effective in Tanzania against disease
caused by buffalo-derived T. parva but not in Kenya (17–20). A
deeper understanding of CD is needed, particularly with regard
to distinguishing CD and improving its control in light of the
reduced efficacy of the vaccine (17).
Most research describing the clinical signs of T. parva
infection (both ECF and CD) has been conducted with
experimentally infected cattle achieved by injecting cattle with
T. parva stabilate or applying infected ticks (3, 10). The purpose
of this paper is to describe in detail the clinical manifestations
and disease progression of CD in a naturally infected Boran
calf population, thus contributing to a more thorough and
detailed description of CD than has historically been described.
In addition, we describe the approach to conducting a clinical
field study, including methods for ensuring naïveté and exposure
in study animals, measuring clinical parameters in the field, and
confirmation of disease and requirements of the study site.
MATERIALS AND METHODS
Animal Care and Use
The study protocols were approved by the International
Livestock Research Institute (ILRI)’s Institutional Animal Care
andUse Committee (references 2013-03, 2014-32, 2015-29, 2017-
02, and 2018-10). The humane endpoint was defined as 10 days
of elevated temperature or if the animal developed severe signs of
disease, particularly recumbency and anorexia, as assessed by two
veterinarians. The animals were treated or euthanized depending
on the severity of the disease.
Study Site
The field studies were conducted at the Ol Pejeta Conservancy
in Laikipia County, Kenya. Ol Pejeta is considered endemic





E; altitude 1,784m (2013) and
00◦00.971’N, 36◦55.171’E; altitude 1,797m (2014–2018), which
is 9 km northeast of the 2013 site. Both sites are routinely grazed
by buffalo and other wildlife but not cattle.
To determine the presence of infected ticks in the study
area, drag sampling with cloth was used to collect ticks
from pasture. Rhipicephalus appendiculatus ticks were identified
morphologically and removed from the cloth with forceps
before being placed in breathable containers with moisture for
transportation to ILRI for further analysis. The tick salivary
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FIGURE 1 | Map of Kenya demonstrating study location, Ol Pejeta
Conservancy, Laikipia County, and source of study animals, Kapiti Research
Station, Machakos County.
glands were removed and examined by microscopy for the
presence of infected acini. DNA was extracted from the glands
and analyzed by polymerase chain reaction (PCR) involving
amplification of the T. parva p67 gene (21).
Study Animals
The study animals were part of five experimental field studies
investigating CD in Boran cattle conducted between 2013 and
2018. The first study in 2013 was an assessment of the Muguga
cocktail live sporozoite vaccine and has been described previously
(17). The subsequent studies (2014–2018) investigated tolerance
to CD in a group of genetically related, unvaccinated cattle
compared with unrelated controls. The results regarding the
genetically related cattle will be reported elsewhere.
Only unvaccinated cattle (2013) and control cattle genetically
unrelated to the animals being studied for tolerance to CD
(2014–2018) were used to conduct the analyses in this paper to
exclude any influence of immunity or pedigree. The relatedness
of cattle was determined by pedigree records and confirmed by
genotyping (22).
Cattle, previously unexposed to T. parva, were purchased
from ILRI’s Kapiti Research Station (Machakos, Kenya) and
transported to Ol Pejeta Conservancy (Laikipia, Kenya)
(Figure 1). Forty-six cattle were observed in the five studies 2013
(n = 9), 2014 (n = 14), 2015 (n = 10), 2017 (n = 7), and 2018
(n = 6). Cattle were aged between 8 and 18 months, and the
majority of the study cattle were steers or bulls (n = 33) except
for 13 heifers (2015 n= 5, 2017 n= 5, and 2018 n= 3).
All cattle tested negative for T. parva exposure or presence
via enzyme-linked immunosorbent assay (ELISA) for antibodies
to the polymorphic immunodominant molecule, a T. parva
antigen expressed by sporozoites and schizonts (23) (all studies)
and nested PCR targeting the p104 gene (24) (2013, 2017,
2018) before transport to the study site, confirming freedom
from disease (Supplementary Table 1). All study cattle were in
good health before transport to the field study site. Preventive
medicine measures included: vaccination against foot-and-
mouth disease (Kenya Veterinary Vaccines Production Institute)
at least 1 month before shipment, treatment with an acaricide
(DuoDip, Norbrook, Nairobi, Kenya) 5 days before shipment,
and a pre-shipment treatment of multivitamins (Norbrook,
Nairobi, Kenya).
Field Study and Clinical Health Assessment
At the study site, cattle were housed in a fenced yard at night and
allowed to graze freely during the day. Ticks attached naturally
onto the cattle, and for ethical reasons, cattle were treated with
acaricide when a heavy tick burden was observed after 10–17
days of the field exposure. After the initial treatment, cattle
were treated with acaricide every 3–7 days to inhibit excessive
tick attachment.
Animal health and clinical observations were assessed daily
by at least two researchers before the cattle were released from
the pens for grazing. In addition, the herders who were with the
cattle around the clock reported any clinical observations such
as anorexia, coughing, diarrhea, weakness, or prolonged periods
of recumbency. Temperatures and clinical signs of disease
(corneal opacity, lacrimation, nasal discharge, cough, labored
breathing, lymph node swelling, body condition, and anorexia)
were included in the health assessment. Any other abnormal
parameters including, but not limited to, stool consistency,
ventral edema (bottle jaw), teeth grinding, and neurological
symptoms were also recorded.
Rectal temperatures were measured daily, and pyrexia was
defined as core body temperature ≥ 39.5◦C (3). Coughing
was recorded if an animal coughed more than once either
during the observation period or throughout the day, labored
breathing was defined as difficulty breathing with or without
wheezing during the morning observation period, lymph node
swelling was determined via palpation and visual assessment,
poor body condition was agreed upon by two researchers during
the observation period, and anorexia was defined as not eating
for at least 1 day or eating extremely little.
Field Sampling and Laboratory Analysis
Blood was collected into ethylenediaminetetraacetic acid
vacutainers (BDTM) from the jugular veins of animals every
day (2015, 2017, and 2018) or every 3–4 days before disease
manifestation and every 1–2 days during acute disease,
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post-initial pyrexia (2013, 2014). Blood was collected into
serum vacutainers (BDTM) every other day (2013) and every 5
days (2014–2018).
Filled ethylenediaminetetraacetic acid and serum vacutainers
were kept cool in ice boxes with frozen ice packs in the field before
transport to the laboratory for analysis. Whole blood was used
to conduct white blood cell (WBC) counts, packed cell volume
(PCV), and aliquots frozen in liquid nitrogen for nested p104
PCR analysis for confirmation of parasite infection, as described
previously (24). Serum was separated by centrifugation at 3,000
rpm for 20min and two aliquots frozen.
WBC counts were conducted using a hemocytometer
throughout the studies in 2015 and 2017, every second day in
2014, and in the last 10 days of the 2013 study. PCVwasmeasured
using a hematocrit reader with a capillary tube, centrifuged at
3,000 rpm for 6min throughout the 2015, 2017, and 2018 studies
and every 3–4 days before disease manifestation and every 1–
2 days during acute disease (2013, 2014). Total plasma protein
(TPP) was estimated every day in the 2015, 2017, and 2018
studies using a refractometer on the supernatant from the PCV
capillary tubes.
Needle biopsies were taken from parotid and pre-scapular
lymph nodes every day (2015, 2017, and 2018) or every second
day (2013 and 2014) from the first day of swelling to the end
of the study or death. In the initial studies, the purpose of the
sampling was to detect macroschizonts and confirm infection;
in subsequent studies, a more systematic approach was taken
to estimate the day of infection. Lymph nodes were sampled
alternately on the left and right sides of the animal to minimize
damage. If a lymph node aspirate was negative three samples
in a row, after being macroschizont-positive, the animal was no
longer sampled.
Enzyme-Linked Immunosorbent Assay
Serum samples collected every 5 days after exposure were
screened for antibodies to T. parva by ELISA as previously
described (23). In brief, microtiter plates were coated with
a recombinant (glutathione-S-transferase) version of the
polymorphic immunodominant molecule antigen. Test serum
samples were added in duplicate at a dilution of 1:200, and
bound antibodies were detected with a horseradish peroxidase-
linked mouse monoclonal antibody specific for bovine IgG1.
After the addition of the substrate hydrogen peroxide and
2,2’-azino-di-[3-ethyl-benzothiazoline-6-sulphonic acid, the
mean OD405 of the two wells was recorded. Interassay variation
was controlled by analyzing four control sera—a strong positive,
a moderately positive, a weak positive, and a negative sample.
The positive sera were obtained from an animal infected with
T. parva Muguga stabilate 3087 (25). Each control serum was
added in quadruplicate, and the resultant OD405 values had to
fall within predetermined limits for the assay to be valid. The
percentage positivity (PP) relative to the strong positive sample
was determined for each sample using the formula: PP = (mean
ODsample/mean ODstrongpositive) × 100. Samples with PP of 20 or
greater were considered positive. The test does not differentiate
between ECF or CD infection.
TABLE 1 | Primers used to detect T. parva genes p67 and p104.
Genes Sequence 5′-3′ Size (bp)
p67 PCR (21) Foward CGACACTGAACGATGCAAATA 2200
Reverse GAGTTATTGTTAGTGGACGAT
p104 PCR (outer) (24) Forward ATTTAAGGAACCTGACGTGACTGC 496
Reverse TAAGATGCCGACTATTAATGACACC
P104 PCR (inner) Forward GGCCAAGGTCTCCTTCAGAATACG 277
Reverse TGGGTGTGTTTCCTCGTCATCTGC
Polymerase Chain Reaction
The p67 PCR was performed as previously described (21). The
master mix consisted of 5 µl of OneTaq R© 2× Master Mix (New
England Biolabs), 0.2 µl each primer (Table 1), 3.1 µl water, and
1.5 µl of DNA. The cycling conditions were 95◦C for 5min, 30
cycles of 95◦C for 1min, 56◦C for 1min, 72◦C for 1min, then
72◦C for 9min and a hold at 4◦C.
The nested p104 PCR was performed as previously described
(24). The master mix consisted of 5 µl of DreamTaq PCR Master
Mix (2×) (Thermo Scientific), 0.2 µl each primer (Table 1), 3.6-
µl water, and 1 µl of DNA (outer primer reaction) or 1-µl
first reaction PCR product (inner primer reaction). The cycling
conditions were 95◦C for 5min, then 30 cycles of 95◦C for 1min,
60◦C for 1min, 72◦C for 1min (outer reactions) or 30 cycles of
95◦C for 1min, 55◦C for 1min, 72◦C for 1min (inner reaction),
then 72◦C for 9min and a hold at 10◦C.
Negative (no DNA) and positive controls were included in
each PCR. The positive control was DNA extracted from blood
drawn from an animal infected with T. parva Muguga stabilate
3087 (25). PCR products underwent electrophoresis through a
1.5% agarose gel with GelRed (Biotium) and were visualized
under ultraviolet light.
Microscopy
Lymph node and blood smears were stained with Giemsa and
examined for the presence of parasites and hyperplastic cells. The
level of macroschizonts was recorded using the following scores:
Ma+, <1 parasite per field; Ma++, 1–2 parasites per field; and
Ma+++, >2 parasites per field under 500× objective (3).
Postmortem Procedure
Cattle that succumbed to infection or were euthanized were
necropsied in the field. The animal was positioned in left lateral
recumbency and a skin incision made from the chin to the
perineum. The skin was reflected and the right limbs abducted.
The abdominal muscles were reflected by cutting along the costal
arch. Rib cutters were used to remove the ribs by cutting along
the sternum and close to the vertebrae. The organs were observed
in situ and then examined for specific gross lesions associated
with CD (4, 26). Digital photographs were taken of the animal
and the organs. The trachea was examined for the presence of
froth. Lungs were examined for evidence of pulmonary edema,
and lymph nodes (pre-scapular and parotid) were examined for
edema and hemorrhage. Lesions were recorded as mild, marked,
or absent.
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Total range Number of
animals with
data points
Mean time to death (days) 21.4 16.2 18.9 17.3 18.8 18.4 15–27 42
Macroschizont—first (days post-challenge) NE NE 10.8 11.9 10.2 11.0 7–14 23
Macroschizont intensity (score 1–3) NE NE 1.59 1.49 1.53 1.55 1–2.4 23
Macroschizont duration (onset to death) NE NE 8.10 5.67 9.25 7.6 4–12 23
Pyrexia—first
(days post challenge)
14.7 14.3 12.8 12.6 13.3 13.7 10–19 46
Pyrexia intensity
(score 1–3)
1.15 1.62 0.99 1.06 1.03 1.23 0.4–3.0 46
Time from pyrexia to death 6.8 2.0 6.1 4.5 6.3 4.76 1.0–13 42
Pyrexia—peak (◦C) 41.3 41.7 41.2 41.2 41.3 41.4 40.2–43.3 46
Pyrexia—peak range (◦C) 40.5–41.7 41.1–43.3 40.6–41.9 40.6–42.0 40.2–41.8 NA NA 46
Pyrexia—peak time (days) 17.6 15.3 16.1 14.9 15.8 15.9 13–22 46
WBC (×106/L) (average last 4 days) NE NE 6200 6700 NE 6400 3,500–9,000 17
PCV (Final PCV/Day 0 PCV × 100) 85% 91% 92% 90% 78% 88% 64–117% 46
Protein (Final Protein/Day 0 Protein × 100) NE NE 74% 72% 63% 70% 57–83% 23
NE, not examined; NA, not applicable.
Confirmation of Infection
Infection with T. parva was confirmed using multiple methods,
microscopy, PCR (24), ELISA (23), and postmortem findings
(13). Impression smears of organs (lung, liver, kidney, spleen,
parotid, and pre-scapular lymph nodes) were collected
postmortem to confirm parasitosis (13).
Descriptive Statistics
Several continuous parameters were assessed (3). Lymph node
infection parameters included the first day of lymph node
positivity (either parotid or pre-scapular as sampling was
dependent on lymph node swelling) and average intensity of
positivity across all lymph node samples. Infection intensity is
based on the number of schizonts seen via microscopy in the
lymph node aspirate samples scored as 1–3 (Ma+ =1, Ma++
=2, and Ma+ + + =3) and divided by the number of days
of schizont detection (3). The duration was measured as days
between infection and death (non-survivors). Pyrexia parameters
included the first day of pyrexia, the average intensity of the
pyrexia over time, the duration of pyrexia per animal, the
days to a peak temperature, and the peak value. Temperature
intensity was the sum of the difference from normal (39.4◦C),
divided by the number of days of pyrexia over 39.4◦C. Piroplasm
parameters included the day of first piroplasm detection,
intensity (presented as the number of piroplasm per 1,000 RBC
counted), and duration.
The agreement between studies was measured using analysis
of variance, in the R environment for statistical computing,
version 3.4.0 (http://cran.r-project.org/), to compare the means
for day to death, the first day of lymph node positivity, the
first day of pyrexia, days to peak temperature, peak temperature
value, temperature intensity, and PCV. The relationship between
the day of death and the described variables was compared
using mixed-effects linear regression models in the lme4
package in R (27) with the study entered as a random effect.
Likelihood ratio tests of the full model with the covariate in
question against the model without the covariate were used to
calculate p-values.
Non-continuous clinical parameters were recorded as present
or absent and included corneal opacity, lacrimation, nasal
discharge, cough, labored breathing, lymph node swelling, loss of
condition, anorexia, neurological signs, teeth grinding, diarrhea,
bottle jaw, and urticaria.
RESULTS
All the cattle (n= 46) developed clinical signs consistent with CD
infection. The mean values of the continuous clinical parameters
for each study are presented in Table 2. A limited number of the
results for the 2013 study have been published elsewhere (17) and
are included in Table 2 here for comparison. Key results for each
parameter are presented later.
Survival
Forty-two (91%) of the 46 animals succumbed to CD, indicating
that the animals were exposed to about a lethal dose of 100%
(LD100) in each study. Of the 42 animals that succumbed, 30 died,
5 were euthanized, and 7 were treated; all 42 animals were in
extremis and considered to have died from CD for the purposes
of this study. One animal survived in each of the 2014 and
2017 studies and two in the 2018 study. There was a significant
difference in the mean time to death between studies [F(4, 37)
= 10.16, p < 0.001]. However, within each study, most animals
succumbed over a relatively short interval of 3–5 days (Figure 2),
suggesting that the animals were uniformly exposed after arrival
at the study site. In this regard, 19 R. appendiculatus ticks (10
females and 9 males) were collected from the pasture at the
study site and examined for the presence of T. parva. Infected
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FIGURE 2 | Number of animals that succumbed to disease post-natural challenge in all five trials. N = 9 (2013), 13 (2014), 10 (2015), 6 (2017), and 4 (2018).
FIGURE 3 | Day of detection of parasitosis in parotid and/or pre-scapular lymph nodes in study animals from three trials N = 10 (2015), 7 (2017), and 6 (2018).
acini were observed in six ticks, and these and a further two
ticks were shown to be positive by both p67 and 18S RNA
gene amplification by PCR; an overall infection rate was 42%.
The abundance calculated by dividing the number of infected
acini (113) by the total number of ticks (19) was 5.95. The
intensity calculated by dividing the number of infected acini
(113) by the number of infected ticks (6) was estimated to
be 18.8.
Lymph Node Parasitosis and Parasitemia
Schizonts were detected in the regional lymph nodes of 45
animals. The one animal that did not have detectable schizonts in
lymph nodes before death nevertheless developed pyrexia on day
14 was seropositive by day 15, and schizonts were observed on
impression smears from organs after death on day 16. The onset
of parasitosis was recorded for cattle in the 2015, 2017, and 2018
studies, but it was difficult to accurately determine the first day
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of lymph node positivity for the 2013 and 2014 studies because
sampling occurred every other day. The first day of parasitosis
was reasonably uniform for the 2015, 2017, and 2018 studies with
no significant difference between the day of onset [F(2, 20) = 2.13,
p = 0.145], with schizonts detected in the majority of animals
(21/23) between days 9 and 13, as shown in Figure 3. There was
no significant relationship between the time to parasitosis and the
time to death (chi2 = 1.12, p= 0.291).
Only two animals were positive for piroplasms, one in 2013
(17) and one in 2015 showing piroplasms for only 1 day.
Pyrexia
As shown in Table 2, several indicators of pyrexia were analyzed.
All animals developed pyrexia, with a mean time to pyrexia of
13.7 days (Table 2), and all but three animals were pyretic by
day 15 (Supplementary Figure 1). The onset of pyrexia varied
between studies [F(4, 41) = 3.22, p= 0.019] as did the time to peak
temperature [F(4, 41) = 4.54, p = 0.004]. Across all studies, there
was a significant relationship between time to pyrexia and time
to death (chi2 = 4.00, p = 0.046), where animals that developed
pyrexia earlier also died sooner. There was also a significant
relationship between the day on which the peak temperature
was observed and the day of death (chi2 = 25.81, p < 0.001),
as animals with an earlier peak temperature died sooner. The
mean time from onset of pyrexia to death was 4.8 days (Table 2),
indicating a relatively short duration of clinical illness. In studies
where parasites were examined every day (2015, 2017, and 2018, n
= 23), almost every animal (n= 19) was observed to have pyrexia
after detecting parasites, with an overall mean delay of 1.9 days
from detection of schizonts to pyrexia.
An indicator of the severity of the pyretic response, peak
temperature, did not vary between studies [F(4, 41) = 1.684, p
= 0.172], and there was a significant relationship between peak
temperature and the day of death, as animals with higher absolute
peak temperatures died sooner than animals with lower peak
temperatures (chi2 = 5.573, p = 0.018). A further indicator of
pyretic response, temperature intensity, did vary between studies
[F(4, 41) = 5.29, p = 0.002] and was significantly associated with
days to death (chi2 = 5.28, p= 0.022).
Fourteen animals showed preterminal hypothermia, in which
abnormally low temperatures (<38◦C) (28) were recorded in the
day immediately before succumbing to the disease.
Packed Cell Volume
The mean PCV decreased slightly throughout the studies in
all years (Supplementary Figure 2), with 22 of 46 animals
developing mild clinical anemia (PCV 21–23%) (29). The mean
values for the final PCV as a percentage of the day 0 PCV for
each study presented in Table 2 also demonstrate the decrease in
PCV throughout the studies. There was a significant relationship
between the percentage change in PCV and days to death
with animals that lived longer having decreased PCV (chi2 =
6.79, p = 0.009). There was a slight increase in PCV between
days 16 and 18 postexposure (Supplementary Figure 2), which
may be explained by a number of animals (n = 11) with a
rising PCV in the days before death, potentially associated with
hemoconcentration from dehydration.
White Blood Cell Counts
ThemeanWBC counts in the 4 days before deaths were 6,200 and
6,700× 106 cells/L for 2015 and 2017, respectively (Table 2). The
WBCs collected in 2013 and 2014 were not collected every day, so
comparisons were not made. In 2015 and 2017, WBC counts in
15 of 16 animals showed a decrease 4 days before death compared
with the WBC at day 0 (Supplementary Figure 3).
Plasma Protein Levels
Total plasma protein was measured in the last three studies
(2015, 2017, and 2018). A gradual decrease in plasma protein
was observed during the course of the studies (Table 2;
Supplementary Figure 4). Almost all animals (21/23) developed
clinical hypoproteinemia (TPP < 60 g/L), with seven animals
severely affected (TPP < 50 g/L) (29).
Anti-T. parva Serology
We had previously observed that only one of the nine control
animals that died in the 2013 study developed a detectable
antibody response to T. parva (17). Of the 37 animals in the
more recent studies, 19 (51%) developed antibodies to T. parva
(Supplementary Table 1). The earliest recorded seroconversion
occurred by day 7, two additional animals seroconverted by day
11, and 14 animals seroconverted by day 16. The results confirm
that T. parva was a constituent of the field challenge and that
seroconversion is not a universal feature of animals that die of
T. parva infection.
Non-Continuous Clinical Signs
The frequencies of non-continuous clinical signs observed in
each of the four studies are listed in Table 3, and the onset of
key clinical signs post-natural exposure is illustrated in Figure 4.
The period of clinical disease was very short, with the mean
day to death only 9 days after the onset of clinical signs
(Figure 4). Figure 4 also includes a graphical representation of
the clinical progression of ECF as described by Jura and Losos
(10). The experiment described by Jura and Losos was a needle
challenge that explains the short incubation period compared
with our study. However, the progression of the disease is much
longer, as evidenced by the number of days of temperature
and macroschizonts.
All of the signs, apart from urticaria, have previously been
implicated in disease caused by T. parva (9, 26). The most
consistently observed signs were nasal discharge, swollen lymph
nodes, and lacrimation, which were also the earliest signs
recorded. Anorexia, labored breathing, and coughing were
also observed in more than 50% of the animals. Conversely,
the least frequent signs were diarrhea, submandibular edema
(“bottle jaw”), and corneal opacity, which developed later in the
progression of the disease. One animal in the 2014 study showed
neurological signs (staggering upon rising).
Gross Pathology
The postmortem findings from the 2013 study have previously
been described (17). Postmortems were conducted on 28 animals
from the 2014, 2015, 2017, and 2018 studies. Necropsy findings
were similar in all animals (Supplementary Table 2). Most
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2014
(n = 14)
1 11 14 7 8 14 6 7 1 4 0 1 0
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(n = 10)
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2017
(n = 7)
2 7 7 6 3 7 3 5 0 1 1 0 3
2018
(n = 6)
5 6 6 3 4 6 6 4 0 1 2 0 0
Total
(n = 46)
10 41 46 33 29 46 22 31 1 14 5 2 5
FIGURE 4 | Timeline of clinical progression of corridor disease using mean day post-exposure for onset and duration of clinical signs and presence and duration of
macroschizonts in lymph node aspirates (blue) compared with timeline of clinical progression of East Coast fever (orange) as described by Jura and Losos (10).
animals had pulmonary edema (n = 27), and many animals had
foam within the airways (n = 25). The parotid and pre-scapular
lymph nodes were enlarged in all animals, and the cut surfaces
were edematous and/or hemorrhagic in most cases (n= 27).
DISCUSSION
This manuscript describes in detail the onset and progression of
clinical signs and clinical pathology of CD in naturally infected
cattle. The additional information from previous reports of CD
is a detailed timeline of the evolution of clinical signs of disease,
detailed clinical pathology manifestations including changes to
PCV, protein andWBC counts, and parasite numbers throughout
the disease and performance of diagnostic tests.
The clinical signs of CD were first described by Neitz in 1955
and included fever, enlarged lymph nodes, anorexia, lacrimation,
nasal discharge, teeth grinding, loss of condition, coughing, and
labored breathing (9). These are also consistent with the signs
reported for ECF (13). Uncommon signs in our study were
diarrhea, bottle jaw, neurological signs, and corneal opacity,
which have been reported as common findings in CD previously
(2). The short duration of infection (mean 7.6 days from
schizonts to death) might have prevented the development of
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these more chronic clinical conditions. The difference in disease
progression and duration between the CD cases described in our
study and a previous study describing ECF are demonstrated in
Figure 4 (10), indicating the rapid progression of the disease in
our study.
The case fatality in the study animals was 91%. Case fatality to
CD in the field in susceptible animals was previously reported
to be ∼80% (9). The mortality is usually lower for ECF, with
case fatality reports for naïve animals under field conditions
ranging from 40 to 60% (6, 30). Factors influencing the case
fatality in ECF endemic areas include acquired immunity in
calves through low but consistent exposure to ticks and low
infection rates in ticks resulting from low parasitemias in carrier
cattle (31). We demonstrated a high infection rate in ticks (42%)
and high abundance and intensity of infected acini per tick (5.95
and 18.8), compared with results reported previously in another
study (2.3%, 3.8 and 0.085, respectively) (32). An alternative
hypothesis may suggest a virulent strain of buffalo-associated
T. parva circulating in the study area, as previous research has
demonstrated that strains of different virulence will result in
different clinical outcomes (18, 33).
There was a significant difference in the time to death between
the five studies. This suggests a seasonal effect on tick populations
(34). In 2013 and 2018, the studies were conducted in June/July
during the colder months, whereas the 2014 and 2015 studies
were conducted in November/December and the 2017 study in
March during the warmer months. Because the outcome of the
disease is dependent on the parasite load, it is possible that
seasonal effects reduced the tick population, the challenge and
the progression of clinical signs (26).
In contrast, within each study, most animals succumbed
within 3 days of each other. Similar observations were made with
respect to the time to parasitosis within each study. Previous
experimental studies with cattle-derived parasites have shown
the time to death, and the detection of parasites in the regional
lymph node is strongly dose-dependent, where the parasites
were delivered as a sporozoite stabilate (10, 35). Jarrett et al.
(36) reported similar results through a detailed analysis of cattle
infected by applying infected ticks, although their study did not
include a determination of the time to death. These observations
suggest that the cattle within each study received a similar dose
of parasites.
In our study, the time to parasitosis of 11.0 days (range 7–
14) and pyrexia 13.7 days (range 10–19) were similar to previous
studies; experimental studies of CD using tick challenge reported
the mean time to pyrexia to be 14.5 days (range 7–23) (37).
Naturally challenged susceptible animals are expected to show
signs of T. parva infection 2–3 weeks after exposure (26).
There was no significant relationship between the time to
parasitosis and the time to death. Previous studies of ECF have
indicated a relationship between lymph node parasitism and the
intensity of macroschizonts with the severity of the disease (3).
However, in CD, the number of macroschizonts remains low
compared with ECF throughout the disease progression and does
not relate to the disease severity observed in this study (10). There
were significant relationships between the time to death and the
time to onset of temperature, peak temperature, and the severity
of pyrexia. This is consistent with previous studies that have
demonstrated that earlier onset (time to pyrexia) and severity of
pyrexia (temperature intensity) are associated with severe disease
(3). The peak temperature value and the days to peak temperature
have not previously been evaluated in the progression of CD, and
these may be explored in the future as potential indicators of the
severity of the disease.
Only two animals developed piroplasms, a finding which is
consistent with previous studies reporting that CD is self-limiting
(there is no carrier state) in the majority of animals (1, 10).
This is different from studies of ECF that report piroplasms in
animals by day 15 (38). As this was a field study with no control
over infections in ticks, we cannot exclude the possibility that
the piroplasms observed were of a theilerial species other than
T. parva.
We demonstrated a slight reduction in PCV over the study
period. This is consistent with reports that ECF causes a drop in
PCV and mild anemia (38, 39). Anemia in ECF is likely caused
by the destruction of RBCs from parasitemia (32). As piroplams
were not observed in this study, theremay be anothermechanism
of anemia in CD related to non-regeneration, which may be the
result of hematopoietic cell destruction (40). Similarly, we saw a
slight reduction in WBC counts, which is consistent with reports
of transient leukopenia in fatal cases of CD (2). This is in contrast
to studies that have described severe leukopenia in ECF-infected
animals (3, 4, 33, 40, 41).
A mild hypoproteinemia was observed in the study animals,
which is consistent with studies of ECF (4). This is likely due
to the loss of protein in oedematous fluids or may be the
result of decreased nutrient intake due to decreased appetite (4).
Severe presentations of hypoproteinemia such as “bottle jaw” or
subcutaneous edema have been reported to be a common clinical
manifestation of CD in other studies but were not observed in
this study (2). There may not have been sufficient time to develop
these overt clinical signs of hypoproteinemia due to the short
duration of infection.
In endemic regions, the diagnosis of ECF or CD is dependent
on the presence and severity of clinical signs and should be
quickly recognized by cattle owners. The appearance of classical
clinical signs, such as nasal discharge, lachrymation, and enlarged
lymph nodes, remain the most useful parameters. Confirmatory
tests such as lymph node aspirates are effective but may not
always be available. We could not compare diagnostic test
performance formally due to the small number of animals but
determined that ELISA is not an effective diagnostic tool, as it
did not detect early cases and not all animals seroconverted.
Seroconversion may also occur in asymptomatic animals making
its use as a clinical diagnostic tool less valuable. Molecular
methods were not assessed in this study and are not likely to
be available to cattle keepers. The progression of CD is rapid, so
early detection is necessary to implement treatment and prevent
lethal outcomes.
Additional to the improved detailed description of clinical
CD and associated diagnostic methods, this manuscript also
importantly describes the approach for conducting a field
experiment for CD in cattle. Apart from seasonal factors outside
of our control, we were able to replicate the study over five
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different occasions with comparable results. The risk with field
experiments is ensuring high constant infection pressure for the
development of clinical disease in a period amenable to the
logistics of maintaining staff at the study site. In this study, we
demonstrated that all animals were clinically affected with CD.
This enabled a thorough description of the disease progression,
including the onset and severity of clinical signs and clinical
pathology. To conduct field studies of this nature, there must
be trained personnel, including veterinarians, animal health,
and laboratory technicians, and adequate, accessible facilities
such as a cattle race and crush/squeeze chute. Apart from the
research staff, there were two experienced cattle handlers with
the study herd 24 h a day. This enabled continual observation
of the clinical progression of disease in the study animals and
accurate estimates of the onset of clinical signs. The study site
was located within Ol Pejeta Conservancy, where the research
team had access to a basic laboratory. However, there were
challenges regarding electricity that was not continuous, and
we required backup batteries to ensure a regular supply and
accessibility of the field site, particularly during the 2013 study
because of heavy rains. Planning for these obstacles should
be considered in advance of any field experiment to avoid
wasting resources.
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